Bulgaria vs French Polynesia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bulgaria
0.0%
in 2024
French Polynesia
0.0%
in 2024
Bulgaria rank
143rd
French Polynesia rank
143rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bulgaria
- French Polynesia
How they compare
Bulgaria currently reports 0.0% against 0.0% in French Polynesia, a difference of 0.0%.
Across all 10 years both countries report, French Polynesia has been ahead every year.
Bulgaria ranks 143rd and French Polynesia ranks 143rd of 215 countries.
Head to head by decade
| Decade | Bulgaria | French Polynesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bulgaria or French Polynesia?
- Bulgaria, at 0.0% against 0.0% in French Polynesia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bulgaria and French Polynesia?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and French Polynesia?
- 10 years are reported by both, from 2015 to 2024.
- How do Bulgaria and French Polynesia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bulgaria ranks 143rd and French Polynesia ranks 143rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.